Folate fortification for the prevention of birth defects: Case study

American Journal of Epidemiology

Volumn 154, Issue 12 SUPPL., 2001, Pages

  Feinleib, Manning ^a,h   Beresford, Shirley A A ^b   Bowman, Barbara A ^c   Mills, James L ^d   Rader, Jeanne I ^e   Selhub, Jacob ^f   Yetley, Elizabeth A ^g  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e U S DEPARTMENT OF AGRICULTURE   (United States)

^f TUFTS UNIVERSITY   (United States)

^g CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^h JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

CHILD HEALTH; EPIDEMIOLOGY;

ADULT; BIRTH DEFECT; CASE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG SAFETY; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; FEMALE; FOOD INTAKE; HUMAN; NEURAL TUBE DEFECT; PROPHYLAXIS; UNITED STATES;

EID: 0035893053     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/154.12.S60     Document Type: Conference Paper

References (51)

1. Final rule on food labeling. Health claims and label statements, folic acid and neural tube defects
2. Folate and neural tube defects
3. Folic acid safety and toxicity: A brief review
4. Folate intake and food sources in the US population
5. The challenge of regulating health claims and food fortification
6. Problems in the diagnosis and investigation of megaloblastic anemia
7. Folic acid preparations, oral and parenteral for therapeutic use; drugs for human use; drug efficacy study implementation
8. Folic acid preparations, oral and parenteral for therapeutic use; drugs for human use; drug efficacy study implementation; amendment
9. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
10. Use of folic acid for prevention of spina bifida and other neural tube defects - 1983-1991
11. Food labeling: Health claims and label statements; folic acid and neural tube defects
12. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects
13. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects
14. Periconceptional use of multivitamins and the occurrence of neural tube defects
15. Periconceptional folic acid exposure and risk of occurrent neural tube defects
16. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation
17. How do we get enough folic acid to prevent some neural tube defects?
18. Folic acid fortification of grain: An economic analysis
19. Let's increase folic acid fortification and include vitamin B-12
20. The unnecessary epidemic of folic acid-preventable spina bifida and anencephaly
21. Urgent need to increase folic acid consumption
22. Food labeling: Health claims and label statements; folate and neural tube defects
23. Food standards: Amendment of standards of identity for enriched grain products to require addition of folic acid
24. Food additives permitted for direct addition to food for human consumption; folic acid (folacin)
25. Prevention of neural tube defects by vitamin supplements
26. The role of folic acid in pregnancy with particular reference to anemia, abruption and abortion
27. Therapeutic abortions with a folic acid antagonist, 4-aminopteroylglutamic acid (4-amino PGA) administered by the oral route
28. Teratogenic effects of pteroylglutamic acid deficiency in the rat
29. Folic acid metabolism and human embryopathy
30. Vitamin deficiencies and neural tube defects
31. Possible prevention of neural-tube defects by periconceptional vitamin supplementation
32. Further experience of vitamin supplementation for prevention of neural tube defect recurrences
33. Quality of diet and blood folate concentrations
34. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects
35. Dietary folate as a risk factor for neural-tube defects: Evidence from a case-control study in Western Australia
36. The absence of a relation between the periconceptional use of vitamins and neural-tube defects
37. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects
38. Folic acid fortification of the food supply: Potential benefits and risks for the elderly population
39. Folate status in women of childbearing age - United States, 1999
40. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects
41. Decline in prevalence of neural tube defects in a high-risk region of the United States